North America Hereditary Testing Market Size & Outlook

The hereditary testing market in North America is expected to reach a projected revenue of US$ 4,210.9 million by 2030. A compound annual growth rate of 8.4% is expected of North America hereditary testing market from 2024 to 2030.

Revenue, 2023 (US$M)
$2,391.6
Forecast, 2030 (US$M)
$4,210.9
CAGR, 2024 - 2030
8.4%
Report Coverage
North America

North America hereditary testing market highlights

  • The North America hereditary testing market generated a revenue of USD 2,391.6 million in 2023.
  • The market is expected to grow at a CAGR of 8.4% from 2024 to 2030.
  • In terms of segment, hereditary non-cancer testing was the largest revenue generating disease type in 2023.
  • Hereditary Cancer Testing is the most lucrative disease type segment registering the fastest growth during the forecast period.
  • Country-wise, Canada is expected to register the highest CAGR from 2024 to 2030.


North America data book summary

Market revenue in 2023USD 2,391.6 million
Market revenue in 2030USD 4,210.9 million
Growth rate8.4% (CAGR from 2023 to 2030)
Largest segmentHereditary non-cancer testing
Fastest growing segmentHereditary Cancer Testing
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationHereditary Cancer Testing, Hereditary Non-cancer Testing
Key market players worldwideMyriad Genetics Inc, Invitae Corp, Illumina Inc, Natera Inc, Labcorp Holdings Inc, Roche Holding AG ADR, Quest Diagnostics Inc, CooperSurgical, Agilent Technologies Inc, Thermo Fisher Scientific Inc, Twist Bioscience Corp, Sophia Genetics SA, Fulgent Genetics Inc, MedGenome, Centogene NV Ordinary Shares, The Cooper Companies Inc


Other key industry trends

  • In terms of revenue, North America region accounted for 32.9% of the global hereditary testing market in 2023.
  • Globally, Europe is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 3,021.9 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Hereditary Testing Market Companies

Name Profile # Employees HQ Website

North America hereditary testing market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hereditary testing market will help companies and investors design strategic landscapes.


Hereditary non-cancer testing was the largest segment with a revenue share of 84.71% in 2023. Horizon Databook has segmented the North America hereditary testing market based on hereditary cancer testing, hereditary non-cancer testing covering the revenue growth of each sub-segment from 2018 to 2030.


North America accounted for a substantial revenue share in 2020, owing to continuous development of hereditary genetic testing solutions by key vendors. For instance, in August 2018, LabCorp’s company Dynacare entered into an agreement with London Health Sciences Centre to conduct genetic testing for Charcot-Marie-Tooth disease, mitochondrial disorders, and epilepsy at its genetics laboratory in Canada.


Dynacare gained exclusive rights to provide multi-gene panel tests to patients throughout the U.S. and a few parts of Canada. Similarly, in September 2019, Finnish company Blueprint Genetics partnered with ARCHIMEDlife, a rare disease diagnostics company, to provide biochemical testing for rare diseases in North America. Through the partnership, both firms planned to diversify their range of genetic disease testing services to better serve North American customers.


Similar initiatives are expected to strengthen genetic testing scenario for hereditary disorders in North America, thereby accelerating regional revenue generation.

Reasons to subscribe to North America hereditary testing market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of North America hereditary testing market databook

  • Our clientele includes a mix of hereditary testing market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the North America hereditary testing market, including forecasts for subscribers. This continent databook contains high-level insights into North America hereditary testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

North America hereditary testing market size, by country, 2018-2030 (US$M)

North America Hereditary Testing Market Share, 2023 & 2030 (US$M)

North America hereditary testing market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more